These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7815506)

  • 1. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1995 Feb; 69(2):1280-3. PubMed ID: 7815506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication.
    Platt TH; Tcherepanova IY; Schildkraut CL
    J Virol; 1993 Mar; 67(3):1739-45. PubMed ID: 8382320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.
    Kirchmaier AL; Sugden B
    J Virol; 1998 Jun; 72(6):4657-66. PubMed ID: 9573229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication.
    Chittenden T; Lupton S; Levine AJ
    J Virol; 1989 Jul; 63(7):3016-25. PubMed ID: 2542609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.
    Leight ER; Sugden B
    J Virol; 2001 Nov; 75(22):10709-20. PubMed ID: 11602712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Reisman D; Sugden B
    Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-stranded structures are present within plasmids containing the Epstein-Barr virus latent origin of replication.
    Orlowski R; Miller G
    J Virol; 1991 Feb; 65(2):677-86. PubMed ID: 1846191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.
    Reisman D; Yates J; Sugden B
    Mol Cell Biol; 1985 Aug; 5(8):1822-32. PubMed ID: 3018528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The linking regions of EBNA1 are essential for its support of replication and transcription.
    Mackey D; Sugden B
    Mol Cell Biol; 1999 May; 19(5):3349-59. PubMed ID: 10207059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats.
    Aiyar A; Aras S; Washington A; Singh G; Luftig RB
    Virol J; 2009 Mar; 6():29. PubMed ID: 19265546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.
    Gahn TA; Schildkraut CL
    Cell; 1989 Aug; 58(3):527-35. PubMed ID: 2547525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats.
    Dhar V; Schildkraut CL
    Mol Cell Biol; 1991 Dec; 11(12):6268-78. PubMed ID: 1658629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
    Wysokenski DA; Yates JL
    J Virol; 1989 Jun; 63(6):2657-66. PubMed ID: 2542579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minimal replicator of Epstein-Barr virus oriP.
    Yates JL; Camiolo SM; Bashaw JM
    J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements.
    Koons MD; Van Scoy S; Hearing J
    J Virol; 2001 Nov; 75(22):10582-92. PubMed ID: 11602700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome.
    Shirakata M; Imadome KI; Hirai K
    Virology; 1999 Oct; 263(1):42-54. PubMed ID: 10544081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.